GlassScriptPhysician profile
Melvin Cohen
NPI 1982715975
$2,462.16
in general payments reported to CMS, 2019-2025
7 companies · $398 in 2025
The $398 reported for 2025 was more than what 88% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,668 · 2020: $13.79 · 2021: $10.70 · 2022: $270 · 2023: $79.93 · 2024: $21.62 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $285 · Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $285.47 |
| Food and Beverage | $213.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $2,058.21 | 2019-2025 | Opalescence |
| Centrix INC | $123.42 | 2019 | |
| Straumann USA LLC | $93.88 | 2023-2025 | |
| Dentsply Sirona INC | $66.14 | 2020-2025 | Tph Spectra Universal Composite Restorative Low Viscosity |
| Voco America INC. | $60.98 | 2019-2024 | Admira Fusion X-Tra, Futurabond U, Profluorid L |
| Orapharma, A Division of Bausch Health US, LLC | $30.33 | 2022-2023 | Arestin |
| Elevate Oral Care | $29.20 | 2023 | Fluorimax Mint, Just Right 5000, Advantage Arrest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melvin Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.